| 產品名稱 |
Avian reovirus |
| 商品貨號 |
B163139 |
| Classification |
Reoviridae, Reovirus |
| Agent |
Avian reovirus |
| Strain |
2177 |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Commercially-reared chickens afflicted with inflammation of the hock joints |
| Product Format |
freeze-dried |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host |
Cytopathic effects (syncytium and giant cell formation) within 5 to 7 days |
| Recommended Host |
chicken embryo fibroblasts chicken embryo, yolk or embryo; chicken embryo fibroblasts |
| Growth Conditions |
Temperature: 37°C Incubation: 2-4 days |
| Cryopreservation |
Storage temperature: -20C for lyophilized; -70C for frozen |
| Name of Depositor |
Univ. Delaware, Akzo Pharmaceuticals |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Commercially-reared chickens afflicted with inflammation of the hock joints |
| References |
Rosenberger JK, et al. Reovirus strain 2177 and vaccine containing same. US Patent 5,525,342 dated Jun 11 1996
RosenbergerCharacterization of Reoviruses Associated with a runting Syndrome in Chickens.In: RosenbergerDisease Prevention and Control in Poultry Production, Aug. 31-Sep 2, 1983Sydney Australia1983.
|
